The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...
from NDTV News - Topstories https://www.ndtv.com/india-news/drug-controller-general-of-india-dgci-approves-commercial-launch-of-low-cost-covid-19-test-feluda-2298124
Saturday, September 19, 2020
Subscribe to:
Post Comments (Atom)
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment